Skip to Main Content

Paper Details

Nuclear FGFR1 Regulates Gene Transcription and Promotes Antiestrogen Resistance in ER<sup>+</sup> Breast Cancer.
Clin Cancer Res
35
2021
Antiestrogen, ER, ER+, ER+ Breast Cancer, ER+ breast cancer, ER+ primary tumors, ER+/FGFR1 overexpressing breast cancer, ER+/FGFR1-amplified breast cancer cells, FGFR, FGFR tyrosine kinase, FGFR1, FGFR1 overexpressing, FGFR1(SP-)(NLS), FOXA1, FOXA1 siRNA, Ki67, MCF7 cells, Nuclear FGFR1, RNA, RNA-Polymerase II, Tumors, antiestrogen, breast cancer, breast cancer cells, chromatin, erdafitinib, estrogen, fulvestrant, gene expression, histone, letrozole, nuclear FGFR1, patients, primary tumors, transcription start sites, tyrosine
Author NameAffiliation
Rahul K KolliparaSimmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center
Paula I Gonzalez-EricssonVanderbilt-Ingram Cancer Center
Saurabh MendirattaSimmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center
Ralf KittlerSimmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center
  • 1 - 4

Datasets

Release 1.2